What it is and how it works
From the published literature on Relaxation PM blend; the papers are listed at the end. Research summary, not a recommendation.
What it is
Relaxation PM is a vendor injectable blend of four compounds: GABA (gamma-aminobutyric acid, the brain's main calming neurotransmitter), melatonin (the pineal hormone that signals night), and the amino acids L-arginine and L-glutamine. No peer-reviewed study of the blend itself was found as of 2026-11-06; the papers below concern its components. Of the four, melatonin has by far the strongest sleep literature, and all of the human sleep evidence comes from oral use, not injection.
How it works
Melatonin is released by the pineal gland at night and acts on two receptors, MT1 and MT2 (G protein-coupled receptors, meaning switches on the cell surface that relay a signal inward), in the brain's circadian clock, which lowers alertness and shifts the timing of the sleep-wake cycle. GABA calms nerve cells by opening chloride channels on them, but a review of GABA supplements found it unclear whether GABA taken into the bloodstream crosses the blood-brain barrier (the filter that keeps many blood-borne molecules out of the brain). L-arginine is the raw material for nitric oxide, a gas that relaxes blood vessels, and L-glutamine is the most abundant amino acid in the body and a fuel for immune and gut cells; neither has an established role in sleep. Any combined effect of the four has not been tested.
What it has been studied for
- Primary insomnia and sleep onset (melatonin meta-analysis of randomized trials)
- Circadian rhythm and sleep regulation through MT1 and MT2 receptors (melatonin review)
- Calming effects of GABA supplements and whether GABA reaches the brain (review)
- Immune and gut-cell fuel in illness and stress (glutamine review)
- Nitric oxide production and blood flow (arginine and amino-acid review)
Strength of the evidence
Human trialsMelatonin has meta-analyses of randomized placebo-controlled sleep trials, while GABA, arginine and glutamine have no convincing sleep trials and the blend itself has never been studied.
What the literature reports on safety
In randomized trials melatonin's adverse effects were few and mostly mild (daytime sleepiness, headache, dizziness), though long-term safety data are limited; GABA, arginine and glutamine are generally well tolerated as foods and supplements, and in a trial of arginine after heart attack enrolment was closed early after more deaths occurred in the arginine group. In the United States melatonin and GABA are sold as dietary supplements; a prolonged-release oral melatonin is a licensed insomnia medicine in Europe, and no injectable sleep blend of these components is an approved drug. Combining sedating products with alcohol or sleep medicines adds to drowsiness.
Key papers
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective (opens in a new tab)
Review · Liu J, Clough SJ, et al. · Annual Review of Pharmacology and Toxicology (2016) · PMID 26514204
Described melatonin's night-time release and its action on the MT1 and MT2 receptors that regulate sleep and circadian rhythms, and the approved drugs that target them.
Review · Boonstra E, de Kleijn R, et al. · Frontiers in Psychology (2015) · PMID 26500584
Found that whether supplemental GABA crosses the blood-brain barrier was unresolved and that the evidence for a calming effect came mostly from researchers with potential conflicts of interest.
Review · Cruzat V, Macedo Rogero M, et al. · Nutrients (2018) · PMID 30360490
Described glutamine as a key fuel for immune cells that can become conditionally essential in severe illness, while noting it was unclear when supplementation should be recommended.
Amino acids: metabolism, functions, and nutrition (opens in a new tab)
Review · Wu G · Amino Acids (2009) · PMID 19301095
Reviewed arginine and glutamine as functional amino acids, with arginine serving as the precursor of nitric oxide, and noted that excess amino acids or their products can also be harmful.
Meta-analysis: melatonin for the treatment of primary sleep disorders (opens in a new tab)
Review · Ferracioli-Oda E, Qawasmi A, et al. · PLoS One (2013) · PMID 23691095
Across 19 randomized placebo-controlled trials with 1,683 people, melatonin shortened the time to fall asleep by about seven minutes and modestly increased total sleep time and sleep quality.
Review · Besag FMC, Vasey MJ, et al. · CNS Drugs (2019) · PMID 31722088
Across 37 randomized trials, melatonin's adverse events were few and mostly mild (daytime sleepiness, headache, dizziness), with no life-threatening events, but long-term data were scarce.
Randomized trial · Schulman SP, Becker LC, et al. · JAMA (2006) · PMID 16391217
Adding arginine after a heart attack did not improve vascular stiffness or heart function, and enrolment was closed early after more deaths occurred in the arginine group than in the placebo group.
Sources checked: PubMed/PMC (E-utilities esummary and abstracts on every PMID), written 2026-11-06.
No sources yet
None of the three teachers' sources we have indexed discuss Relaxation PM blend yet. This page will fill in as sources are added.
Deeper guided audio lives on What Am I Appreciating Now (leaves this site, opens in a new tab). What Am I Appreciating Now is a separate site run by the same operator; it sells meditation and hypnosis sessions.
Disclaimer: for research purposes only
All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.